Search Results - Roughead, E.

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    How much do we spend on prescription medicines?: Out-of-pocket costs for patients in Australia and other OECD countries

    How much do we spend on prescription medicines?: Out-of-pocket costs for patients in Australia and other OECD countries by Kemp, A., Preen, D., Glover, J., Semmens, James, Roughead, E.

    Published 2011
    Get full text
  2. 2
    Impact of cost of medicines for chronic conditions on low income households in Australia

    Impact of cost of medicines for chronic conditions on low income households in Australia by Kemp, A., Preen, D., Glover, J., Semmens, James, Roughead, E.

    Published 2013
    Get full text
    Get full text
  3. 3
    Determinants of self-reported medicine underuse due to cost: a comparison of seven countries

    Determinants of self-reported medicine underuse due to cost: a comparison of seven countries by Kemp, A., Roughead, E., Preen, D., Glover, J., Semmens, James

    Published 2010
    Get full text
  4. 4
    The impact of co-payment increases on dispensings of government-subsidised medicines in Australia

    The impact of co-payment increases on dispensings of government-subsidised medicines in Australia by Hynd, A., Roughead, E., Preen, D., Glover, J., Bulsara, M, Semmens, James

    Published 2008
    Get full text
  5. 5
    Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia

    Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia by Hynd, A., Roughead, E., Preen, D., Glover, J., Bulsara, M, Semmens, James

    Published 2009
    Get full text
  6. 6
    Have increases in co-payments for medicines further burdened Australians in remote and disadvantaged areas?

    Have increases in co-payments for medicines further burdened Australians in remote and disadvantaged areas? by Kemp, A., Glover, J., Preen, D., Bulsara, M., Semmens, James, Roughead, E.

    Published 2012
    Get full text
    Get full text
  7. 7
    Evaluating pharmaceutical policy impacts using interrupted time series analysis: An Australian case study

    Evaluating pharmaceutical policy impacts using interrupted time series analysis: An Australian case study by Kemp, A., Preen, D., Sanfilippo, F., Glover, J., Semmens, James, Roughead, E.

    Published 2011
    Get full text
    Get full text
  8. 8
    From the city to the bush: Increases in patient co-payments for medicines have impacted on medicine use across Australia

    From the city to the bush: Increases in patient co-payments for medicines have impacted on medicine use across Australia by Kemp, A., Glover, J., Preen, D., Bulsara, M., Semmens, James, Roughead, E.

    Published 2013
    Get full text
  9. 9
    Early discontinuation of endocrine therapy for breast cancer: Who is at risk in clinical practice?

    Early discontinuation of endocrine therapy for breast cancer: Who is at risk in clinical practice? by Kemp, A., Preen, D., Saunders, C., Boyle, F., Bulsara, M., Malacova, Eva, Roughead, E.

    Published 2014
    Get full text
  10. 10
    HALF OF WOMEN WITH EARLY BREAST CANCER STOP ENDOCRINE THERAPY BEFORE FIVE YEARS: RESULTS FROM AN AUSTRALIAN POPULATION-BASED STUDY

    HALF OF WOMEN WITH EARLY BREAST CANCER STOP ENDOCRINE THERAPY BEFORE FIVE YEARS: RESULTS FROM AN AUSTRALIAN POPULATION-BASED STUDY by Kemp, A., Roughead, E., Saunders, C., Boyle, F., Bulsara, M., Malacova, Eva, Preen, D.

    Published 2014
    Get full text
  11. 11
    Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: The impact of comorbidity and demographics on initial choice

    Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: The impact of comorbidity and demographics on initial choice by Kemp, A., Preen, D., Saunders, C., Boyle, F., Bulsara, M., Holman, C., Malacova, Eva, Roughead, E.

    Published 2014
    Get full text

Search Tools: